Cargando…

Dexmedetomidine Attenuates Apoptosis and Neurological Deficits by Modulating Neuronal NADPH Oxidase 2-Derived Oxidative Stress in Neonates Following Hypoxic Brain Injury

Hypoxic–ischemic brain injury is an important cause of neonatal neurological deficits. Our previous study demonstrated that dexmedetomidine (Dex) provided neuroprotection against neonatal hypoxic brain injury; however, the underlying mechanisms remain incompletely elucidated. Overactivation of NADPH...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiaohui, Chen, Dongtai, Chen, Pinzhong, Chen, Andi, Deng, Jianhui, Wei, Jianjie, Zeng, Weian, Zheng, Xiaochun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686745/
https://www.ncbi.nlm.nih.gov/pubmed/36358571
http://dx.doi.org/10.3390/antiox11112199
_version_ 1784835829641773056
author Chen, Xiaohui
Chen, Dongtai
Chen, Pinzhong
Chen, Andi
Deng, Jianhui
Wei, Jianjie
Zeng, Weian
Zheng, Xiaochun
author_facet Chen, Xiaohui
Chen, Dongtai
Chen, Pinzhong
Chen, Andi
Deng, Jianhui
Wei, Jianjie
Zeng, Weian
Zheng, Xiaochun
author_sort Chen, Xiaohui
collection PubMed
description Hypoxic–ischemic brain injury is an important cause of neonatal neurological deficits. Our previous study demonstrated that dexmedetomidine (Dex) provided neuroprotection against neonatal hypoxic brain injury; however, the underlying mechanisms remain incompletely elucidated. Overactivation of NADPH oxidase 2 (NOX2) can cause neuronal apoptosis and neurological deficits. Hence, we aimed to investigate the role of neuronal NOX2 in Dex-mediated neuroprotection and to explore its potential mechanisms. Hypoxic injury was modeled in neonatal rodents in vivo and in cultured hippocampal neurons in vitro. Our results showed that pre- or post-treatment with Dex improved the neurological deficits and alleviated the hippocampal neuronal damage and apoptosis caused by neonatal hypoxia. In addition, Dex treatment significantly suppressed hypoxia-induced neuronal NOX2 activation; it also reduced oxidative stress, as evidenced by decreases in intracellular reactive oxygen species (ROS) production, malondialdehyde, and 8-hydroxy-2-deoxyguanosine, as well as increases in the antioxidant enzymatic activity of superoxide dismutase and glutathione peroxidase in neonatal rat hippocampi and in hippocampal neurons. Lastly, the posthypoxicneuroprotective action of Dex was almost completely abolished in NOX2-deficient neonatal mice and NOX2-knockdown neurons. In conclusion, our data demonstrated that neuronal NOX2-mediated oxidative stress is involved in the neuroprotection that Dex provides against apoptosis and neurological deficits in neonates following hypoxia.
format Online
Article
Text
id pubmed-9686745
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96867452022-11-25 Dexmedetomidine Attenuates Apoptosis and Neurological Deficits by Modulating Neuronal NADPH Oxidase 2-Derived Oxidative Stress in Neonates Following Hypoxic Brain Injury Chen, Xiaohui Chen, Dongtai Chen, Pinzhong Chen, Andi Deng, Jianhui Wei, Jianjie Zeng, Weian Zheng, Xiaochun Antioxidants (Basel) Article Hypoxic–ischemic brain injury is an important cause of neonatal neurological deficits. Our previous study demonstrated that dexmedetomidine (Dex) provided neuroprotection against neonatal hypoxic brain injury; however, the underlying mechanisms remain incompletely elucidated. Overactivation of NADPH oxidase 2 (NOX2) can cause neuronal apoptosis and neurological deficits. Hence, we aimed to investigate the role of neuronal NOX2 in Dex-mediated neuroprotection and to explore its potential mechanisms. Hypoxic injury was modeled in neonatal rodents in vivo and in cultured hippocampal neurons in vitro. Our results showed that pre- or post-treatment with Dex improved the neurological deficits and alleviated the hippocampal neuronal damage and apoptosis caused by neonatal hypoxia. In addition, Dex treatment significantly suppressed hypoxia-induced neuronal NOX2 activation; it also reduced oxidative stress, as evidenced by decreases in intracellular reactive oxygen species (ROS) production, malondialdehyde, and 8-hydroxy-2-deoxyguanosine, as well as increases in the antioxidant enzymatic activity of superoxide dismutase and glutathione peroxidase in neonatal rat hippocampi and in hippocampal neurons. Lastly, the posthypoxicneuroprotective action of Dex was almost completely abolished in NOX2-deficient neonatal mice and NOX2-knockdown neurons. In conclusion, our data demonstrated that neuronal NOX2-mediated oxidative stress is involved in the neuroprotection that Dex provides against apoptosis and neurological deficits in neonates following hypoxia. MDPI 2022-11-07 /pmc/articles/PMC9686745/ /pubmed/36358571 http://dx.doi.org/10.3390/antiox11112199 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Chen, Xiaohui
Chen, Dongtai
Chen, Pinzhong
Chen, Andi
Deng, Jianhui
Wei, Jianjie
Zeng, Weian
Zheng, Xiaochun
Dexmedetomidine Attenuates Apoptosis and Neurological Deficits by Modulating Neuronal NADPH Oxidase 2-Derived Oxidative Stress in Neonates Following Hypoxic Brain Injury
title Dexmedetomidine Attenuates Apoptosis and Neurological Deficits by Modulating Neuronal NADPH Oxidase 2-Derived Oxidative Stress in Neonates Following Hypoxic Brain Injury
title_full Dexmedetomidine Attenuates Apoptosis and Neurological Deficits by Modulating Neuronal NADPH Oxidase 2-Derived Oxidative Stress in Neonates Following Hypoxic Brain Injury
title_fullStr Dexmedetomidine Attenuates Apoptosis and Neurological Deficits by Modulating Neuronal NADPH Oxidase 2-Derived Oxidative Stress in Neonates Following Hypoxic Brain Injury
title_full_unstemmed Dexmedetomidine Attenuates Apoptosis and Neurological Deficits by Modulating Neuronal NADPH Oxidase 2-Derived Oxidative Stress in Neonates Following Hypoxic Brain Injury
title_short Dexmedetomidine Attenuates Apoptosis and Neurological Deficits by Modulating Neuronal NADPH Oxidase 2-Derived Oxidative Stress in Neonates Following Hypoxic Brain Injury
title_sort dexmedetomidine attenuates apoptosis and neurological deficits by modulating neuronal nadph oxidase 2-derived oxidative stress in neonates following hypoxic brain injury
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686745/
https://www.ncbi.nlm.nih.gov/pubmed/36358571
http://dx.doi.org/10.3390/antiox11112199
work_keys_str_mv AT chenxiaohui dexmedetomidineattenuatesapoptosisandneurologicaldeficitsbymodulatingneuronalnadphoxidase2derivedoxidativestressinneonatesfollowinghypoxicbraininjury
AT chendongtai dexmedetomidineattenuatesapoptosisandneurologicaldeficitsbymodulatingneuronalnadphoxidase2derivedoxidativestressinneonatesfollowinghypoxicbraininjury
AT chenpinzhong dexmedetomidineattenuatesapoptosisandneurologicaldeficitsbymodulatingneuronalnadphoxidase2derivedoxidativestressinneonatesfollowinghypoxicbraininjury
AT chenandi dexmedetomidineattenuatesapoptosisandneurologicaldeficitsbymodulatingneuronalnadphoxidase2derivedoxidativestressinneonatesfollowinghypoxicbraininjury
AT dengjianhui dexmedetomidineattenuatesapoptosisandneurologicaldeficitsbymodulatingneuronalnadphoxidase2derivedoxidativestressinneonatesfollowinghypoxicbraininjury
AT weijianjie dexmedetomidineattenuatesapoptosisandneurologicaldeficitsbymodulatingneuronalnadphoxidase2derivedoxidativestressinneonatesfollowinghypoxicbraininjury
AT zengweian dexmedetomidineattenuatesapoptosisandneurologicaldeficitsbymodulatingneuronalnadphoxidase2derivedoxidativestressinneonatesfollowinghypoxicbraininjury
AT zhengxiaochun dexmedetomidineattenuatesapoptosisandneurologicaldeficitsbymodulatingneuronalnadphoxidase2derivedoxidativestressinneonatesfollowinghypoxicbraininjury